Navigation Links
Contract Services for Big Pharma and Biotechs Driving Growth and Innovation from Discovery to Clinical Trials
Date:2/6/2008

NEW YORK, Feb. 6 /PRNewswire/ -- Over the past few years, the strategic importance of the global pharmaceutical marketplace has become increasingly apparent. Multinational interest and investment in the global pharmaceutical industry is at an all-time high and competition is heating up. On one hand big pharma is pumping in more resources into outsourcing and offshoring. On the other hand, drug safety issues, threat from biogenerics, stricter protocols for APIs and pharmacovigilance issues question some existing models and frameworks. More than ever, as the demand intensifies to fill the pharmaceutical pipeline with new drugs and therapeutics -- outsourcing partnerships are playing an increasingly critical role.

The 2008 BioPharma Outsourcing: Partnerships with CROs and Other Service Providers forum, scheduled for March 25-26, 2008 at the Hilton Boston Back Bay in Boston, MA is designed to bring together pharma and biotech executives from around the world to gather strategic information and creating networking relationships all eager to facilitate new investments and partnerships.
Distinguished Speaker Roster Includes (updated as of February 6, 2008):

-- Diana M. Galer Ph.D., VP, Strategic Management Group, Pfizer Global

Research & Development

-- Mark Tracy, Senior Director, Pharmaceutical Operations, Alnylam

Pharmaceuticals

-- RoseAnn Price, Alliance Management, Amgen

-- Mel Sorensen, M.D., President & CEO, Ascenta Therapeutics, Inc.

-- Ahsan Awan, JD, MBA, CRCP, Global CINRG, Inc.

-- Gur Roshwalb, MD, VP & Senior Analyst Health Care, Piper Jaffray

& Co.

-- Han Gunn, Preclinical Director, Department of Pharmacokinetics & Drug

Metabolism, Amgen

-- Partha S. Ray, MD, CEO, IndusPharma Consulting Group

-- Michael Palladino, PhD, Senior VP, CTO, & Scientific Co-Founder,

Nereus Pharmaceuticals

-- Steve J. Bannister, PhD, Chief Scientific Officer, Xcelience, LLC

-- Judd Berman, PhD., Chief Scientific Officer, Dalton Medicinal

Chemistry

-- Zhengming (Jimmy) Chen, PhD, Senior Director, Chemistry and CMC,

DOV Pharmaceutical, Inc.

-- John Lemelan, General Partner, Riverside Partners

-- Dean Wilson, PhD, Research Fellow, Vertex Pharmaceuticals

-- John Maclennan, PhD, Director, Business Development, Wolfe

Laboratories, Inc.

For Complete List of Speakers, Detailed Agenda, and to Register: http://www.iibig.com/P0803

Call: 212-300-2523

E-mail: rial@iibig.com


'/>"/>
SOURCE iiBIG
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Vestibular Technologies Is Awarded Contract by Major Group Purchasing Organization (GPO)
2. DNA is blueprint, contractor and construction worker for new structures
3. Clinimetrics Celebrates 20th Anniversary in Contract Research Business
4. Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthenes Legal Action in Breach of Contract Lawsuit Against SIGA
5. Helix BioPharma Corp. contracts KBI Biopharma to develop an L-DOS47 clinical packaging format
6. HealthTrust Expands Contract With Instrumentation Laboratory for Critical Care Portfolio to Include Consorta
7. Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program
8. The Tauri Group LLC Awarded U.S. Department of Homeland Security Chemical and Biological Early Detection Systems Program Office Support Contract
9. EDS Awarded $715 Million Contract for Bristol-Myers Squibb Information Services
10. Smart Medical Technology, Inc. Awarded Novation Contract for Ground-breaking Liftaem(TM) System that Aids Lifting and Transferring Patients
11. ICx Awarded Department of Defense Contract for AirSentinel Monitors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of ... the Cary 5000 and the 6000i models are higher end machines that use the ... of the spectrophotometer’s light beam from the bottom of the cuvette holder. , ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader ... “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, ... providing practical tips, tools, and strategies for clinical researchers. , “The landscape of ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... , June 23, 2016 A person commits a ... crime scene to track the criminal down. An ... Food and Drug Administration (FDA) uses DNA evidence to track ... Sound far-fetched? It,s not. The FDA has increasingly ... support investigations of foodborne illnesses. Put as simply as possible, ...
Breaking Biology Technology:
(Date:4/28/2016)... Sweden , April 28, 2016 First ... M (139.9), up 966% compared with the first quarter of 2015 ... profit totaled SEK 589.1 M (loss: 18.8) and the operating margin ... 7.12 (loss: 0.32) Cash flow from operations was SEK ... The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:3/31/2016)... 31, 2016   ... the "Company") LegacyXChange is excited to release ... soon to be launched online site for trading 100% ... ) will also provide potential shareholders a sense of ... to an industry that is notorious for fraud. The ...
Breaking Biology News(10 mins):